Cooperative Agreement U01CK000719

This Project Grant award of $133,203 was provided by the National Science Foundation (NSF) through its Mathematical and Physical Sciences (CFDA 47.049) program. The award supports a collaborative research project among the University of Florida, University of Georgia, and University of Massachusetts Amherst to develop advanced mathematical models to improve understanding and management of schistosomiasis transmission dynamics, with a focus on the transition from high to low transmission phases...

The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program to the University of California, Los Angeles (UCLA) to develop a rapid, multiplexed diagnostic tool for serological testing of tick-borne diseases (TBDs). This 2-year project seeks to improve blood-based detection of TBDs, including Lyme disease, Babesia, Anaplasma, and relapsing fever, through an innovative point-of-care (POC) serological assay. The goal is...

The National Institute of Allergy and Infectious Diseases awarded $599,709 to L2 Diagnostics LLC on September 23, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a transmission-blocking vaccine targeting mosquito metabolic pathways to interrupt malaria spread. L2 Diagnostics LLC, a for-profit small business based in Woodbridge, Connecticut, is refining a prototype vaccine candidate that targets four novel metabolic proteins in Anopheles mosquitoes. The...

The Project Grant award of $214,291 from the National Science Foundation's Office of International Science and Engineering (CFDA 47.079) supports the "ACCELNET DESIGN: INTEGRATING GLOBAL NETWORKS TO ADVANCE PARASITE ECOLOGY AND TRANSMISSION RESEARCH AT THE HUMAN-ANIMAL-ENVIRONMENT INTERFACE" project. This effort aims to establish an international network of researchers focused on understanding the global distribution and transmission of the Toxoplasma gondii parasite, a significant...

The National Institute of Allergy and Infectious Diseases awarded Kephera Diagnostics LLC $303,250 on August 24, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a rapid diagnostic immunoassay for strongyloidiasis caused by Strongyloides stercoralis. The award funds Phase I research to identify novel and improved biomarkers for detecting strongyloidiasis through in-silico and high-throughput screening to map immunodominant epitopes. The work addresses...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

The National Institute of Allergy and Infectious Diseases awarded Yale University $1,377,692 on April 13, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to decipher residual malaria transmission mechanisms in the Peruvian Amazon and inform novel control strategies. Yale will characterize sociodemographic, behavioral, environmental, and genetic factors contributing to individual malaria reinfection risk in the Amazon, estimate the relative contribution of genetic...

The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, awarded $554,155 to Global Animal Health Tanzania on September 15, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the effectiveness of oral rabies vaccination in controlling canine and human rabies. The research will evaluate whether integrating oral rabies vaccination (ORV) into existing mass dog vaccination programs can increase coverage...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...